Scholarlink

<p>Inflammatory Bowel Disease (IBD) is a persistent ailment that impacts many individuals worldwide. The interaction between the immune system and gut microbiome is thought to influence IBD development. This study aimed to assess some microbiota in IBD patients compared to healthy individuals. The investigation involved a selected group of twenty patients suffering from IBD and an equal number of healthy participants. Stool specimens were obtained and analyzed for <i>Lactobacillus</i>, <i>Bifidobacterium</i>, <i>Bacteroides</i>, <i>Clostridium leptum</i>, <i>Akkermansia muciniphila</i>, <i>Fusobacterium</i> and <i>Enterobacteriaceae</i> using real-time PCR. The findings indicated significantly higher levels of <i>Bifidobacterium</i> in IBD patients (<i>Pv</i> = 0.009) and lower levels of <i>A. muciniphila</i> (<i>Pv</i> = 0.003) healthy individuals. Other bacteria tested did not show significant differences. The study suggests that the progression of IBD patients could be influenced by the rising of <i>Bifidobacterium</i> and the declining of <i>A. muciniphila</i>. Targeting these bacteria could lead to improved treatments and quality of life for those with IBD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of variations in predominant gut microbiota members in inflammatory bowel disease using real-time PCR

  • 期刊论文

  • 发表日期：

    2025年1月21日

查看全文
  • Mina Tasoujlu,
  • Yaeghob Sharifi,
  • Maryam Ghahremani,
  • Kasra Alizadeh,
  • Farhad Babaie,
  • Mohammadreza Mohammad Hosseiniazar

摘要

Inflammatory Bowel Disease (IBD) is a persistent ailment that impacts many individuals worldwide. The interaction between the immune system and gut microbiome is thought to influence IBD development. This study aimed to assess some microbiota in IBD patients compared to healthy individuals. The investigation involved a selected group of twenty patients suffering from IBD and an equal number of healthy participants. Stool specimens were obtained and analyzed for Lactobacillus, Bifidobacterium, Bacteroides, Clostridium leptum, Akkermansia muciniphila, Fusobacterium and Enterobacteriaceae using real-time PCR. The findings indicated significantly higher levels of Bifidobacterium in IBD patients (Pv = 0.009) and lower levels of A. muciniphila (Pv = 0.003) healthy individuals. Other bacteria tested did not show significant differences. The study suggests that the progression of IBD patients could be influenced by the rising of Bifidobacterium and the declining of A. muciniphila. Targeting these bacteria could lead to improved treatments and quality of life for those with IBD.